PARIS: A long-term study of women who used ovary-stimulating hormones for fertility treatment found no widespread evidence of a higher cancer risk, researchers said on Monday.

The results appear to contradict a number of studies in recent years that suggested such treatments may increase the risk of the disease.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details